AI Verdict
OBK has stronger fundamentals based on our AI analysis.
OBK vs OBIO Fundamental Comparison
| Metric | OBK | OBIO |
|---|---|---|
| Revenue | $538.0M | $33.5M |
| Net Income | $75.2M | $-52.7M |
| Net Margin | 14.0% | -157.4% |
| ROE | 6.0% | -98.4% |
| ROA | 0.8% | -45.9% |
| Current Ratio | N/A | 6.45x |
| Debt/Equity | 0.00x | 0.28x |
| EPS | $2.40 | $-1.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OBK vs OBIO: Frequently Asked Questions
Is OBK or OBIO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OBK has stronger fundamentals. OBK is rated HOLD (68% confidence) while OBIO is rated SELL (74% confidence). This is not investment advice.
How does OBK compare to OBIO fundamentally?
Origin Bancorp, Inc. has ROE of 6.0% vs Orchestra BioMed Holdings, Inc.'s -98.4%. Net margins are 14.0% vs -157.4% respectively.
Which stock pays higher dividends, OBK or OBIO?
OBK has a dividend yield of N/A or no dividend while OBIO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OBK or OBIO for long term?
For long-term investing, consider that OBK has HOLD rating with 68% confidence, while OBIO has SELL rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OBK vs OBIO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OBK vs OBIO, the AI consensus favors OBK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.